Q-omics provides the consensus-scored RNU6-590P profile across patient tissues and cancer cell-line models. RNU6-590P expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in PAAD. Additionally, RNU6-590P RNA expression shows 5,694 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight PAAD, and STAD as cancer lineages where RNU6-590P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-590P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-590P survival associations across molecular data types. RNU6-590P RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-590P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	PAAD (72)	view →

This table ranks reproducible RNU6-590P RNA expression–survival associations across cancer types. High RNU6-590P expression shows unfavorable associations in PAAD and STAD. The PAAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify PAAD as the clearest survival context for RNU6-590P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.100	0.614	<.001	72	view →
STAD	OS	Tertile	All	0.061	0.731	<.001	36	view →

Pink = unfavorable, green = favorable. all 2 lineages →

RNU6-590P-PAAD (OS)

Kaplan–Meier survival curve for RNU6-590P RNA expression in PAAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-590P in patient tissues and cancer cell lines. In patient samples, RNU6-590P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	5,694	STAD (2905)	view →
Function (RNA)	5,264	STAD (5176)	view →